C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 99 filers reported holding C4 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CITIGROUP INC | 18,402 | $50,606 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 39,287 | $123,361 | 0.00% |
| BARCLAYS PLC | 33,368 | $92 | 0.00% |
| HSBC HOLDINGS PLC | 32,653 | $90,286 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 231,034 | $635,344 | 0.00% |
| GOLDMAN SACHS GROUP INC | 230,566 | $634,057 | 0.00% |
| MORGAN STANLEY | 241,039 | $662,858 | 0.00% |
| Invesco Ltd. | 55,910 | $153,753 | 0.00% |
| JPMORGAN CHASE & CO | 1,503 | $4,133 | 0.00% |
| BlackRock Inc. | 2,086,563 | $5,738,049 | 0.00% |
| Bank of New York Mellon Corp | 22,281 | $61,273 | 0.00% |
| Citadel Advisors | 31,700 | $87,175 | 0.00% |
| Citadel Advisors | 1,900 | $5,225 | 0.00% |
| Citadel Advisors | 669,482 | $1,841,076 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 225,192 | $619,278 | 0.00% |
| TD ASSET MANAGEMENT INC | 48,453 | $133,246 | 0.00% |
| CWM, LLC | 156 | $0 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 16,730 | $46,008 | 0.00% |
| FEDERATED HERMES, INC. | 402 | $1,106 | 0.00% |
| JANE STREET GROUP, LLC | 98,565 | $271,054 | 0.00% |
External links
This page lists C4 THERAPEUTICS INC's shareholders in Q2 2023. To view C4 THERAPEUTICS INC's shareholder history, click here.